Exhibiting at VIV Asia 2025

Qilu Animal Health Products Co., Ltd. is a leading Chinese manufacturer of veterinary pharmaceuticals, dedicated to improving animal health, enhancing food safety, and contributing to human well-being. Headquartered in Jinan, Shandong Province, the company operates as a subsidiary of the larger Qilu Pharmaceutical Group, a globally recognized name in human and veterinary medicine manufacturing. With over 20 years of experience in animal health innovation, Qilu Animal Health has built a strong reputation for its R&D-driven approach, high manufacturing standards, and global distribution capabilities.

Core Business and Product Offerings

Qilu Animal Health provides a full-spectrum portfolio of veterinary pharmaceutical solutions. Its products serve the livestock, poultry, aquaculture, and companion animal sectors. The company’s offerings include:

• APIs (Active Pharmaceutical Ingredients): Supplying high-quality veterinary-grade APIs for global B2B clients.
• Injectables:
  • OTC 200 (Oxytetracycline Injection): A broad-spectrum antibiotic for livestock bacterial infections.
• Intramammary Syringes: Targeted therapies for mastitis management in dairy cows.
• Oral Solutions: Liquid formulations for easy administration in poultry and swine.
• Powder Formulations:
  • Herbal Extract Powders
  • Soluble Therapeutic Powders
  • Premix Nutritional Powders
• Disinfectants:
  • ProteQ: A biosecure disinfectant line for animal housing and equipment.
• Feed Additives: Nutritional and therapeutic additives for gut health, immunity, and performance.
• Vaccines: Includes both live and inactivated vaccines for major livestock and poultry diseases.

These products are manufactured in GMP-certified facilities and are aligned with international pharmacopoeial standards, allowing the company to compete in regulated global markets.

Specialization and Unique Selling Proposition (USP)

Qilu Animal Health’s key differentiator lies in its vertically integrated model and deep pharmaceutical expertise from its parent group, Qilu Pharmaceutical. This enables the company to:

• Develop veterinary-specific APIs in-house
• Scale products from R&D to full GMP production rapidly
• Offer regulatory support for product registration across global jurisdictions
• Maintain stringent quality control through dedicated QC labs

Its USP is the combination of high product efficacy, regulatory compliance, and supply chain reliability, making it a preferred partner for both private label manufacturing and direct importers in over 50 countries.

Market Reach and Target Segments

Qilu Animal Health serves a wide array of customers:

• Veterinary distributors and wholesalers
• Livestock integrators
• Poultry and aquaculture farms
• Governmental procurement agencies
• Private label brands

The company exports to over 50 countries, with a significant presence in Southeast Asia, the Middle East, Latin America, and Eastern Europe. Their participation in global trade shows such as VIV Asia, CPhI, and China International Animal Husbandry Expo has enhanced visibility and customer engagement.

Financial and Operational Highlights

While specific revenue figures for Qilu Animal Health are not published independently, its parent company, Qilu Pharmaceutical Group, reported consolidated revenues exceeding RMB 30 billion (~USD 4.5 billion) in recent years. Within that framework:

• Veterinary division contribution is estimated at USD 100–150 million annually
• Operates multiple production lines across APIs, injectables, oral liquids, and biologics
• Employs 500+ personnel across manufacturing, R&D, and regulatory functions

Export and Shipment Records

According to available international trade databases:

• Qilu Animal Health has completed over 500 export shipments in the last five years
• Top destinations include Vietnam, Egypt, Mexico, the Philippines, and Nigeria
• Frequent exports include OTC injectables, oral liquids, and soluble powder antibiotics

The company offers flexible MOQs (Minimum Order Quantities), multilingual product labeling, and regulatory dossier support, making them a preferred OEM partner globally.

Certifications and Regulatory Compliance

Qilu Animal Health maintains the highest standards in veterinary pharmaceutical manufacturing:

• GMP Certified (China GMP, EU GMP for select facilities)
• ISO 9001:2015 Quality Management System
• VICH Guidelines-aligned product dossiers for international submissions
• Licensed Vaccine Manufacturing under Chinese Ministry of Agriculture
• Environmental Compliance under Chinese EPA for effluent and emissions

These certifications ensure eligibility for registration in both emerging and developed markets.

Research and Development Capabilities

• In-house R&D Center: Employs over 100 researchers focused on drug formulation, pharmacokinetics, and clinical trials
• Pipeline: Includes new-generation antibiotics, natural feed additives, and innovative biologics
• Active collaboration with veterinary universities and research institutes across China

Qilu is continuously investing in biologics and vaccine innovation, targeting diseases with growing resistance concerns or under-addressed segments like aquaculture.

Customer Testimonials and Industry Reputation

Feedback from trade show interviews and distributor networks highlights:

“Qilu’s quality and packaging standards exceed many other Chinese veterinary suppliers. We’ve worked with them for over five years with zero quality incidents.”
— Distributor, Southeast Asia

“Their technical dossiers are thorough and speed up our local registration process significantly.”
— Regulatory Consultant, Middle East

Qilu’s reputation for dependable supply chains and strict quality protocols has made it a go-to choice for government tenders and veterinary importers alike.

Achievements and Milestones

• Over 20 years in animal health manufacturing
• Export partnerships in 50+ countries
• Recognized by China Veterinary Drug Association for excellence in innovation
• Multiple product approvals in regulated markets like Brazil, Egypt, and the Philippines
• Featured in national veterinary science journals for R&D contributions

With its strong pharmaceutical legacy, global outreach, and product reliability, Qilu Animal Health Products Co., Ltd. continues to be a major force in the international veterinary pharmaceutical sector.